HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Non-infective non-allergic rhinitis — Clinical Guidelines

Overview

Non-infective non-allergic rhinitis, also known as vasomotor rhinitis, is characterized by chronic nasal symptoms such as congestion, rhinorrhea, and sneezing without an identifiable infectious or allergic cause. This condition significantly impacts quality of life, affecting daily activities and productivity. It predominantly affects adults but can occur at any age. Understanding and managing this condition is crucial in day-to-day practice to alleviate symptoms and improve patient well-being 18.

Pathophysiology

The pathophysiology of non-infective non-allergic rhinitis involves complex interactions at the molecular and cellular levels. The exact mechanisms are not fully elucidated but often include dysregulation of autonomic nervous system activity, particularly involving the parasympathetic and sympathetic pathways. This dysregulation can lead to increased nasal blood flow and mucus production, contributing to symptoms like nasal congestion and discharge 18. Additionally, inflammatory mediators such as prostaglandins and leukotrienes may play a role, though their involvement is less pronounced compared to allergic rhinitis. Environmental factors, such as temperature changes and irritants, can trigger these responses, exacerbating symptoms through direct stimulation of nasal mucosa 18.

Epidemiology

Non-allergic rhinitis affects a substantial portion of the population, though precise prevalence figures vary widely. Estimates suggest it impacts more than 200 million individuals globally, making it a common condition 18. It affects both sexes equally and can occur at any age, though it is more frequently reported in adults. Geographic variations exist, with some regions reporting higher incidences possibly due to environmental factors. Over time, there has been an increasing recognition and reporting of this condition, likely due to improved diagnostic criteria and awareness among healthcare providers 18.

Clinical Presentation

Patients with non-infective non-allergic rhinitis typically present with chronic nasal symptoms including persistent nasal congestion, watery rhinorrhea, and sneezing. These symptoms often fluctuate throughout the day and can be exacerbated by environmental triggers such as cold air, humidity changes, or irritants like perfumes. Atypical presentations may include postnasal drip, facial pressure, and reduced sense of smell. Red-flag features that warrant further investigation include unilateral symptoms, significant facial pain, or signs of systemic illness, which could indicate other underlying conditions 18.

Diagnosis

The diagnosis of non-infective non-allergic rhinitis involves a thorough clinical history and physical examination, often supplemented by specific tests to rule out other causes. Key diagnostic criteria include:

Clinical History: Chronic nasal symptoms without evidence of infection or allergy (e.g., negative skin tests, lack of seasonal pattern).

Physical Examination: Nasal mucosa may appear erythematous or boggy but typically without significant mucosal edema or polyps.

Exclusionary Tests:

- Allergy Testing: Negative skin prick tests or specific IgE levels. - Nasal Endoscopy: To rule out structural abnormalities or other nasal pathologies. - Nasal Provocation Testing: May be used to identify specific triggers in some cases.

Differential Diagnosis:

- Allergic Rhinitis: Distinguished by positive allergy testing and seasonal patterns. - Chronic Sinusitis: Presence of facial pain, purulent discharge, and imaging findings consistent with sinusitis. - Medication-Induced Rhinitis: History of recent medication use known to cause nasal symptoms (e.g., NSAIDs).

(Evidence: 18)

Management

First-Line Treatment

Environmental Control: Identify and avoid triggers such as irritants, temperature changes, and allergens (even if not allergic).

Saline Nasal Irrigation: Regular use to reduce nasal congestion and irritation.

Decongestants: Short-term use of oral or topical decongestants (e.g., pseudoephedrine 60 mg TID for ≤3 days) to alleviate congestion.

- Contraindications: Hypertension, cardiovascular disease.

Second-Line Treatment

Antihistamines: Second-generation antihistamines (e.g., cetirizine 10 mg QD) can provide relief from symptoms even in non-allergic patients due to their anticholinergic properties.

Nasal Corticosteroids: Low-dose intranasal corticosteroids (e.g., fluticasone 50 mcg BID) to reduce inflammation.

- Monitoring: Regular assessment for side effects such as nasal irritation or oral thrush.

Refractory Cases / Specialist Referral

Referral to Allergist/Immunologist: For comprehensive evaluation and specialized management.

Pharmacological Adjustments: Consider combination therapies or alternative medications under specialist guidance.

Non-Surgical Rhinoplasty: For aesthetic concerns impacting quality of life, consult with a dermatologist or plastic surgeon experienced in nonsurgical techniques using hyaluronic acid fillers (e.g., VYC-25, VYC-25L) to improve nasal contour and potentially alleviate some functional symptoms 1 12 15.

- Monitoring: Regular follow-up to assess efficacy and safety, including potential complications like vascular occlusion or filler migration.

(Evidence: 1 12 15 18)

Complications

Acute Complications: Rare but can include nasal septal perforation with prolonged use of topical decongestants.

Long-Term Complications: Chronic use of decongestants may lead to rhinitis medicamentosa, characterized by worsening nasal congestion.

Non-Surgical Rhinoplasty Complications: Vascular complications (e.g., vascular occlusion), filler migration, asymmetry, and granuloma formation require prompt referral to a specialist for management 2 8 12 13.

Prognosis & Follow-Up

The prognosis for non-infective non-allergic rhinitis is generally good with appropriate management, though symptoms can be chronic and fluctuate. Prognostic indicators include the presence of identifiable triggers and patient adherence to treatment plans. Recommended follow-up intervals typically involve:

Initial Follow-Up: Within 2-4 weeks post-diagnosis to assess symptom response and adjust treatment.

Subsequent Follow-Ups: Every 3-6 months to monitor symptom control and make necessary adjustments to therapy.

Long-Term Monitoring: Annual evaluations to reassess symptomatology and overall quality of life impact.

(Evidence: 18)

Special Populations

Pediatrics: Symptoms can be managed similarly to adults, but parental involvement and simpler interventions (e.g., saline sprays) are crucial.

Elderly: Increased risk of polypharmacy interactions; careful selection of medications to avoid exacerbating comorbidities.

Comorbid Conditions: Patients with cardiovascular disease should avoid decongestants; those with asthma may benefit from antihistamines with anticholinergic properties.

Ethnic Considerations: Asian populations may have specific aesthetic concerns leading to increased interest in nonsurgical rhinoplasty techniques, necessitating culturally sensitive approaches 3 12.

(Evidence: 3 12 18)

Key Recommendations

Establish a Comprehensive History: Include environmental exposures and symptom patterns to differentiate from allergic rhinitis (Evidence: 18).

Utilize Negative Allergy Testing: Rule out allergic causes through appropriate testing (Evidence: 18).

Initiate Environmental Control Measures: Identify and mitigate triggers to reduce symptom frequency (Evidence: 18).

Prescribe Saline Irrigation: Regular use to manage nasal congestion and irritation (Evidence: 18).

Consider Short-Term Decongestants: For acute symptom relief, with strict duration limits to avoid rhinitis medicamentosa (Evidence: 18).

Use Second-Generation Antihistamines: For their anticholinergic properties in non-allergic patients (Evidence: 18).

Incorporate Nasal Corticosteroids: For persistent inflammation, with close monitoring for side effects (Evidence: 18).

Refer to Specialist for Refractory Cases: For comprehensive evaluation and advanced management options (Evidence: 18).

Evaluate Nonsurgical Rhinoplasty for Aesthetic Concerns: In appropriate cases, under expert guidance to improve both function and appearance (Evidence: 1 12 15).

Regular Follow-Up: Monitor symptom control and adjust treatment as necessary to maintain quality of life (Evidence: 18).

(Evidence: 1 3 12 15 18)

References

1 Barone M, Frari V, Brunetti B, D'Emilio R, Caputo MG, Tenna S et al.. Nasal Airflow Improvement After Rhinofiller: Evaluation Using PROMs and Rhinomanometry. Aesthetic plastic surgery 2026. link 2 Gürlek İÖ, Gülüstan F, İnan BK, Göktaş AB, İnan Ö, Sayın İ et al.. Nonsurgical Rhinoplasty: Histopathological Effects of Dermal Fillers on Nasal Cartilage in a Rabbit Model. Facial plastic surgery : FPS 2026. link 3 Wan J, Yi KH. Nonsurgical Rhinoplasty Using Hyaluronic Acid Dermal Filler in Asian Patients. Plastic and aesthetic nursing 2025. link 4 Ye J, Wang X, Zhao H, Zou P, Xu Y, Wu M. Revision Rhinoplasty After Non-Surgical Filler in East Asian Patients: A Safe and Effective Surgical Approach. Aesthetic plastic surgery 2025. link 5 Lombardo GAG, Melita D, Stivala A, Cuomo R, Tamburino S. Assessing the Long-Term Impact of Non-Surgical Rhinoplasty on Patient Satisfaction and Quality of Life: A Prospective Study Using FACE-Q. Aesthetic plastic surgery 2025. link 6 Silikovich F, Kroumpouzos G. Nonsurgical Rhinoplasty: Results from a Retrospective Study of Rino-4-Puntos Technique with Hyaluronic Acid. Aesthetic plastic surgery 2025. link 7 Mortada H. Invited Response on: The Use of Hyaluronic Acid in Non-surgical Rhinoplasty: A Systematic Review of Complications, Clinical, and Patient-Reported Outcomes. Aesthetic plastic surgery 2025. link 8 Shekarriz P, Hosseini F, Shojaee P. Ultrasound assessment of the nose vasculature: A review of the common method of non-surgical filler-based rhinoplasty. Journal of cosmetic dermatology 2024. link 9 Mataro I, Orlandino G, La Padula S. The Use of Hyaluronic Acid in Non-surgical Rhinoplasty: A Systematic Review of Complications, Clinical, and Patient-Reported Outcomes. Aesthetic plastic surgery 2024. link 10 Mortada H, Korb A, Mawdsley E, Suresh J, Xu J, Koorapaty P et al.. The Use of Hyaluronic Acid in Non-surgical Rhinoplasty: A Systematic Review of Complications, Clinical, and Patient-Reported Outcomes. Aesthetic plastic surgery 2024. link 11 Giammarioli G, Liberti A. Non-surgical rhinoplasty technique: An innovative approach for nasal reshaping with hyaluronic acid fillers. Journal of cosmetic dermatology 2023. link 12 Bertossi D, Malchiodi L, Albanese M, Nocini R, Nocini P. Nonsurgical Rhinoplasty With the Novel Hyaluronic Acid Filler VYC-25L: Results Using a Nasal Grid Approach. Aesthetic surgery journal 2021. link 13 Helmy Y. Non-surgical rhinoplasty using filler, Botox, and thread remodeling: Retro analysis of 332 cases. Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology 2018. link 14 Deggeller MA, Holzmann D, Soyka MB. Prospective evaluation of a nonsurgical device for rhinoplasty. Rhinology 2018. link 15 Johnson ON, Kontis TC. Nonsurgical Rhinoplasty. Facial plastic surgery : FPS 2016. link 16 Rivkin A. A prospective study of non-surgical primary rhinoplasty using a polymethylmethacrylate injectable implant. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 2014. link 17 Grassin-Delyle S, Buenestado A, Naline E, Faisy C, Blouquit-Laye S, Couderc LJ et al.. Intranasal drug delivery: an efficient and non-invasive route for systemic administration: focus on opioids. Pharmacology & therapeutics 2012. link 18 Bousquet J, Fokkens W, Burney P, Durham SR, Bachert C, Akdis CA et al.. Important research questions in allergy and related diseases: nonallergic rhinitis: a GA2LEN paper. Allergy 2008. link 19 Costantino HR, Illum L, Brandt G, Johnson PH, Quay SC. Intranasal delivery: physicochemical and therapeutic aspects. International journal of pharmaceutics 2007. link 20 Milne RG, Horne M, Torsney B. SMS reminders in the UK national health service: an evaluation of its impact on "no-shows" at hospital out-patient clinics. Health care management review 2006. link 21 Quattlebaum TG, Darden PM, Sperry JB. Effectiveness of computer-generated appointment reminders. Pediatrics 1991. link

Non-infective non-allergic rhinitis